The Oncology Institute, Inc.
TOI
$3.31
$0.082.48%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -13.18M | -16.11M | -15.48M | -19.89M | -18.75M |
| Total Depreciation and Amortization | 1.71M | 1.57M | 1.52M | 1.49M | 1.58M |
| Total Amortization of Deferred Charges | 1.59M | 1.59M | 1.57M | 1.56M | 1.57M |
| Total Other Non-Cash Items | 1.33M | 2.31M | 142.00K | 3.69M | 5.27M |
| Change in Net Operating Assets | 12.73M | 11.46M | -3.41M | -2.73M | 6.45M |
| Cash from Operations | 4.19M | 819.00K | -15.66M | -15.88M | -3.89M |
| Capital Expenditure | -1.76M | 402.00K | -1.83M | -610.00K | -861.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -156.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 10.00M | 20.00M | 20.00M | 12.64M |
| Cash from Investing | -1.76M | 10.40M | 18.18M | 19.39M | 11.63M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.17M | 991.00K | -9.00K | -1.01M | -3.28M |
| Issuance of Common Stock | 0.00 | 0.00 | 2.00K | 73.00K | 113.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.00M | -1.23M | -2.14M | -- | 1.39M |
| Cash from Financing | -164.00K | -243.00K | -2.15M | -938.00K | -1.78M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.27M | 10.98M | 369.00K | 2.57M | 5.95M |